Yersinia pestis Interacts With SIGNR1 (CD209b) for Promoting Host Dissemination and Infection
Kun Yang(Shanxi Medical University), Tie Chen(Shenzhen University Health Science Center), Sara Schesser Bartra(University of Miami), Biao Kan(National Institute for Communicable Disease Control and Prevention), Chae Gyu Park(Yonsei University), Ding Ma(Fudan University Shanghai Cancer Center), Xiaoling Ying(Second Affiliated Hospital of Guangzhou Medical University), Svetlana V. Dentovskaya(State Research Center for Applied Microbiology and Biotechnology), Yujun Cui(Institute of Microbiology), Lingyu Jiang(Tongji Hospital), Andrey P. Anisimov(State Research Center for Applied Microbiology and Biotechnology), Mikael Skurnik(University of Helsinki), Xiding Xiamu(Shihezi University), Silvia Bulgheresi(University of Vienna), Young Sun Kang(FIND), Wei Li(Guangxi Maternal and Child Health Hospital), Olivia Adhiambo Njiri(Chuka University), Gang Chen(Tongji Hospital), Pei Zhang(Westlake University), Xin Wang(Northwest A&F University), Ruifu Yang(Academy of Military Medical Sciences), Yuanzhi Wang(Shihezi University), Yanping Han(Institute of Microbiology), Meiying Yan(National Institute for Communicable Disease Control and Prevention), Huaiqi Jing(National Institute for Communicable Disease Control and Prevention), Guoxing Zheng(University of Illinois Chicago, Rockford campus), Yingxia He(Flower Hospital), Shusheng Zhang(Hunan Normal University), Lianxu Xia(National Institute for Communicable Disease Control and Prevention), Gregory V. Plano(University of Miami), Honghui Ding, John D. Klena(Centers for Disease Control and Prevention)
Cited by 31
Related Papers
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
|JAMA Internal Medicine|2020|747
Genome Sequence of <i>Yersinia pestis</i> KIM
|Journal of Bacteriology|2002|541
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
|Cell Metabolism|2019|521
United States Food and Drug Administration Drug Approval Summary
|Clinical Cancer Research|2004|500